{"schema_version":"alpha-profile-public-v1","slug":"lynn-seely-m-d","canonical_url":"https://registry.alpha.ac/people/lynn-seely-m-d","as_of":"2026-09-21T20:06:00.357338+00:00","published_at":"2026-09-02T02:37:21.438448+00:00","last_reviewed_at":"2026-05-16T05:07:09.904+00:00","identity":{"display_name":"Lynn Seely, M.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":{"company_name":"Lyell Immunopharma, Inc.","company_slug":"lyell-immunopharma-inc","exchange":"NASDAQ","ticker":"LYEL","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:31:00.497+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=lynn-seely-m-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=lynn-seely-m-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Seely has served as President and CEO of Lyell Immunopharma since December 2022. She was previously President, CEO and board member of Myovant Sciences, where she oversaw the launch of ORGOVYX and MYFEMBREE. Prior to Myovant, she served as Chief Medical Officer of Medivation, overseeing the development and approval of XTANDI for prostate cancer."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Lyell Immunopharma, Inc.","organizationId":"lyell-immunopharma-inc","title":"Director","period":"2021-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Lyell Immunopharma, Inc.","company_slug":"lyell-immunopharma-inc","exchange":"NASDAQ","ticker":"LYEL","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":false,"valid_from":"2021-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:31:00.497+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Lynn Seely, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.321023+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Executive extraction classified AI/ML experience for Lynn Seely, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T05:07:10.145691+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-16T05:07:09.964894+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"LYEL","role_type":"Director","organization":"Lyell Immunopharma, Inc."},"claim_text":"Serves on the board of Lyell Immunopharma, Inc. as Director.","claim_state":"verified","valid_from":"2021-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Lynn Seely, M.D. currently serves as Director at Lyell Immunopharma, Inc..","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.28286+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Lynn Seely, M.D. serves on no disclosed committees.","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.302472+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Lyell Immunopharma, Inc.","claim_text":"Lynn Seely, M.D. is linked to Lyell Immunopharma, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.43992+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"President and Chief Executive Officer","claim_text":"Lynn Seely, M.D. is also listed as President and Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.418661+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Lynn Seely, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.360064+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for Lynn Seely, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T05:07:10.183456+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-16T05:07:09.964894+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2021},"claim_text":"Director tenure at Lyell Immunopharma, Inc. begins from 2021.","claim_state":"verified","valid_from":"2021-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Lyell Immunopharma, Inc.","claim_text":"Lynn Seely, M.D. is associated with Lyell Immunopharma, Inc..","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T05:07:10.130694+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-16T05:07:09.964894+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"President, Chief Executive Officer and Director","claim_text":"Lynn Seely, M.D. is listed as President, Chief Executive Officer and Director at Lyell Immunopharma, Inc..","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T05:07:10.113662+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-16T05:07:09.964894+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":false},"claim_text":"Board independence status at Lyell Immunopharma, Inc.: False.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Lynn Seely, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:51.33982+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:51.196979+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Executive extraction classified technology background for Lynn Seely, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T05:07:10.161315+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-16T05:07:09.964894+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:lynn-seely-m-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2021-01-01 · current","organization":"Lyell Immunopharma, Inc.","organization_id":"lyell-immunopharma-inc"},"claim_text":"Director at Lyell Immunopharma, Inc. (2021-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/lynn-seely-m-d#profile","url":"https://registry.alpha.ac/people/lynn-seely-m-d","dateModified":"2026-05-16T05:07:09.904+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/lynn-seely-m-d#person","name":"Lynn Seely, M.D.","url":"https://registry.alpha.ac/people/lynn-seely-m-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Lyell Immunopharma, Inc.","tickerSymbol":"NASDAQ: LYEL"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","memberOf":{"@type":"Organization","name":"Lyell Immunopharma, Inc.","url":"https://registry.alpha.ac/companies/lyell-immunopharma-inc","tickerSymbol":"NASDAQ: LYEL"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","name":"LYEL DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/lynn-seely-m-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":5,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":11,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":5,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":6,"corroborated":5,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":11,"corroborated_claims":5,"sources":5,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T05:07:09.904+00:00","observed_at":"2026-09-21T20:06:00.357338+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"lynn-seely-m-d","canonical_url":"https://registry.alpha.ac/people/lynn-seely-m-d"},"publication":{"published_at":"2026-09-02T02:37:21.438448+00:00","last_reviewed_at":"2026-05-16T05:07:09.904+00:00","as_of":"2026-09-21T20:06:00.357338+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/lynn-seely-m-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/lynn-seely-m-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/lynn-seely-m-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}